SCHEMBL6160893

SCHEMBL6160893

O=C1[N]N(C2CCCNC2)C(c2ccncc2)=C1c1ccc(Cl)cc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.37
BRAF P15056 1/20 0.35
MAPK11 Q15759 4/20 0.34
MAPK14 Q16539 4/20 0.34
MAPK13 O15264 2/20 0.34
MAPK12 P53778 2/20 0.34
KCNH2 Q12809 1/20 0.34
RIPK3 Q9Y572 1/20 0.34
GCGR P47871 2/20 0.33
MAPKAPK2 P49137 1/20 0.33
AKT1 P31749 1/20 0.33
ABCB1 P08183 1/20 0.33
RAF1 P04049 1/20 0.33
MAPK9 P45984 1/20 0.33
PBK Q96KB5 1/20 0.32
LSS P48449 1/20 0.32
HTR3A P46098 1/20 0.32
RPS6KA5 O75582 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159161 0.86 KCNH2 (0.38) MAPK11MAPK14MAPK13MAPK12KCNH2
SCHEMBL6162408 0.80 HTR6 (0.38) HTR6MAPK11MAPK14MAPK13MAPK12
SCHEMBL6160345 0.76 NR3C1 (0.37) MAPK11MAPK14MAPK13MAPK12AKT1
SCHEMBL6164467 0.72 RIPK3 (0.40) BRAFMAPK11MAPK14KCNH2RIPK3
SCHEMBL5215301 0.72 RIPK3 (0.41) HTR6BRAFMAPK11MAPK14MAPK13
SCHEMBL6163249 0.69 GCGR (0.40) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL1922019 0.65 EGFR (0.45) HTR6BRAFKCNH2RPS6KA5
SCHEMBL6160846 0.62 GCGR (0.47) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL5769180 0.61 GCGR (0.46) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL22795541 0.60 MAPK11 (0.53) MAPK11MAPK14MAPK13MAPK12KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1542680-A1 1, 4, 5-SUBSTITUTED 1, 2-DIHYDRO-PYRAZOL-3-ONE AND 3-ALKOXY-1H-PYRAZOLE DERIVATIVES S TNF-ALPHA AND INTERLEUKIN LOWERING AGENTS FOR THE TREATMENT OF INFLAMMATIONS Amgen Inc. (US) 2005-06-22 EP claimed
WO-2004022055-A1 1, 4, 5-SUBSTITUTED 1, 2-DIHYDRO-PYRAZOL-3-ONE AND 3-ALKOXY-1H-PYRAZOLE DERIVATIVES S TNF-ALPHA AND INTERLEUKIN LOWERING AGENTS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2004-03-18 WO claimed
EP-1542680-A1 1, 4, 5-SUBSTITUTED 1, 2-DIHYDRO-PYRAZOL-3-ONE AND 3-ALKOXY-1H-PYRAZOLE DERIVATIVES S TNF-ALPHA AND INTERLEUKIN LOWERING AGENTS FOR THE TREATMENT OF INFLAMMATIONS Amgen Inc. (US) 2005-06-22 EP disclosed
WO-2004022055-A1 1, 4, 5-SUBSTITUTED 1, 2-DIHYDRO-PYRAZOL-3-ONE AND 3-ALKOXY-1H-PYRAZOLE DERIVATIVES S TNF-ALPHA AND INTERLEUKIN LOWERING AGENTS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2004-03-18 WO disclosed